18 January 2024
Ropes & Gray Advises Aquiline in Majority Investment in PharmaForce
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Scott Abramowitz | Ropes & Gray | Partner | private equity | Not stated |
| Sam Levitt | Ropes & Gray | Partner | private equity | Not stated |
| Alyssa Kollmeyer | Ropes & Gray | Partner | tax | Not stated |
| Jordan Altman | Ropes & Gray | Partner | IP transactions | Not stated |
| Margaux Hall | Ropes & Gray | Partner | health care | Not stated |
| Jennifer Romig | Ropes & Gray | Partner | health care | Not stated |
| Danna Kivell | Ropes & Gray | Partner | executive compensation & employee benefits | Not stated |
| Ama Adams | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Samer Musallam | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Stephanie Bruce | Ropes & Gray | Partner | employment | Not stated |
| Andrea Hwang | Ropes & Gray | Partner | finance | Not stated |
| Nichole Lopez-Tackett | Ropes & Gray | Partner | finance | Not stated |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Aquiline Capital Partners LPBuy-side
- Counterparties
- Pharma Force Group LLC (Sell-side)